Crossmark

Novel RP-HPLC method for simultaneous determination of dapagliflozin and teneligliptin in tablet formulation and identification of degradation products by LC-MS/MS

Crossref DOI link: https://doi.org/10.1186/s43094-024-00734-x

Published Online: 2024-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kashyap, Thummar https://orcid.org/0000-0002-5603-2330
Honey, Kevat

Priyanka, Vadher

Mihir, Jesur
License Information

Text and Data Mining valid from 2024-11-11

Version of Record valid from 2024-11-11
More Information

Article History

Received: 16 May 2024

Accepted: 27 October 2024

First Online: 11 November 2024

Declarations

:

: Not applicable for this section.

: All authors agreed to publish the article in this journal.

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Document is current

Any future updates will be listed below